Todd Bazemore

(Mr. Todd Bazemore)

Currently holds positions in Kala Pharmaceuticals Inc and Santhera Pharmaceuticals Holding AG

Positions

Position Company Period
Chief Operating Officer Kala Pharmaceuticals Inc Nov. 20, 2017 -
Chief Operating Officer Santhera U.S., Member of the Executive Management Board Santhera Pharmaceuticals Holding AG Sept. 6, 2016 -
Executive Vice President and Chief Commercial Officer Dyax Corp April 16, 2014 - Jan. 22, 2016
Todd Bazemore's trades of Kala Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-06-27 2024-06-26
PS Planned sale
4,653 -5.3%
4.75
USD 22,102 		4,653 -5.3% 4.75 USD 22,102
2024-06-03 2024-05-31
PS Planned sale
2,093 -2.3%
6.09
USD 12,746 		2,093 -2.3% 6.09 USD 12,746
2023-01-06 2023-01-04
PS Planned sale
62 -0.4%
28.54
USD 1,769 		62 -0.4% 28.54 USD 1,769
2022-10-28 2022-10-26
PS Planned sale
214 -9.3%
6.51
USD 1,393 		214 -9.3% 6.51 USD 1,393
2022-06-29 2022-06-27
PS Planned sale
3,092 -2.6%
0.37
USD 1,144 		3,092 -2.6% 0.37 USD 1,144
2022-01-05 2022-01-04
PS Planned sale
3,454 -2.8%
1.30
USD 4,490 		3,454 -2.8% 1.30 USD 4,490
2021-10-28 2021-10-26
PS Planned sale
12,544 -9.3%
1.80
USD 22,579 		12,544 -9.3% 1.80 USD 22,579
2020-10-28 2020-10-22
B Purchase
40 +2000.0%
7.60
USD 304 		40 +2000.0% 7.60 USD 304
2020-10-28 2020-06-05
B Purchase
2 +inf%
13.39
USD 27 		2 +inf% 13.39 USD 27
2020-03-17 2020-03-16
B Purchase
10,000 +inf%
5.75
USD 57,500 		10,000 +inf% 5.75 USD 57,500
// ... existing code ... // ... rest of the file ...